Clinical trial

Clinical Application and Usability of Blood Biomarkers As Screening Tool in Alzheimer Disease: a Validation Study

NCT06699992

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention Blood biomarkers quantification Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Clinical Application and Usability of Blood Biomarkers As Screening Tool in Alzheimer Disease: a Validation Study

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2024-12-01

PhaseN/A

Conditions

Cognitive Declineunresolved

Interventions

Blood biomarkers quantificationDIAGNOSTIC_TEST

Sponsors & collaborators

Fondazione Policlinico Universitario Agostino Gemelli IRCCSlead sponsor

Istituto Superiore di Sanitàcollaborator

Azienda Ospedaliera dei Collicollaborator

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermocollaborator

A.O.U. Città della Salute e della Scienzacollaborator

Neurologia Arzignano AULSS8 Bericacollaborator

Azienda Ospedaliero-Universitaria di Modenacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06699992 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.